Detection of human papillomavirus DNA and p53 gene mutations in human prostate cancer

Prostate

Volumn 28, Issue 5, 1996, Pages 318-324

  Suzuki, Hiroyoshi ^a   Komiya, Akira ^a   Aida, Sara ^a   Ito, Haruo ^b   Yatani, Ryuichi ^c   Shimazaki, Jun ^a  

^a CHIBA UNIVERSITY   (Japan)

^b TEIKYO UNIVERSITY CHIBA MEDICAL CENTER   (Japan)

^c MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

genetic alteration; human papillomavirus; p53 gene; prostate cancer

Indexed keywords

PROTEIN P53; VIRUS DNA;

ARTICLE; GENE MUTATION; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE CANCER; VIRUS CARCINOGENESIS; VIRUS GENE; WART VIRUS;

ADENOCARCINOMA; BASE SEQUENCE; DNA, VIRAL; GENES, P53; HUMANS; MALE; MOLECULAR SEQUENCE DATA; MUTATION; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROSTATIC NEOPLASMS;

EID: 0029871033     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(199605)28:5<318::AID-PROS8>3.0.CO;2-7     Document Type: Article

References (31)

1. Suzuki H, Sato N, Watabe Y, Masai M, Seino S, Shimazaki J: Androgen receptor gene mutations in human prostate cancer. J Steroid Biochem Mol Biol 46:759-765, 1993.
2. Suzuki H, Aida S, Akimoto S, Igarashi T, Yatani R, Shimazaki J: State of adenomatous polyposis coli gene and ras oncogenes in Japanese prostate cancer. Jpn J Cancer Res 85:847-852, 1994.
3. Hollstein M, Sidransky D, Vogelstein B, Harris CC: p53 mutations in human cancers. Science 253:49-53, 1991.
4. Levine AJ, Momand J, Finlay CA: The p53 tumor suppressor gene. Nature 351:453-456, 1991.
5. Isaacs WB, Carter BS, Ewing CM: Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles. Cancer Res 51:4716-4720, 1991.
6. Dürst M, Gissmann L, Ikenberg H, Zur Hausen H: A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci USA 80:3812-3815, 1983.
7. Fukushima M, Okagaki T, Twiggs LB, Clark BA, Zachow KR, Ostrow RS, Faras AJ: Histological types of carcinoma of the uterine cervix and the detectability of human papillomavirus DNA. Cancer Res 45:3252-3255, 1985.
8. Suzuki H, Sato N, Kodama T, Okano T, Isaka S, Shirasawa H, Simizu B, Shimazaki J: Detection of human papillomavirus DNA and state of p53 gene in Japanese penile cancer. Jpn J Clin Oncol 24:1-6, 1994.
9. Furihata M, Inoue K, Ohtsuki Y, Hashimoto H, Terano N, Fujita Y: High-risk human papillomavirus infections and overexpression of p53 protein as prognostic indicators in transitional cell carcinoma of the urinary bladder. Cancer Res 53:4823-4827, 1993.
10. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM: The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129-1136, 1990.
11. Werness BA, Levine AJ, Howley PM: Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248:76-79, 1990.
12. Yoshikawa H, Kawana T, Kitagawa K, Mizuno M, Yoshikura H, Iwamoto A: Detection and typing of multiple genital human papillomaviruses by DNA amplification with consensus primers. Jpn J Cancer Res 82: 524-531, 1991.
13. Uzawa K, Yoshida H, Suzuki H, Tanzawa H, Shimazaki J, Seino S, Sato K: Abnormalities of the adenomatous polyposis coli gene in human oral squamous cell carcinoma. Int J Cancer 58:814-817, 1994.
14. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61:759-767, 1990.
15. Bookstein R, Macgrogan D, Hilsenbeck SG, Sharkey F, Allred DC: p53 is mutated in a subset of advancedstage prostate cancers. Cancer Res 53:3369-3373, 1993.
16. Dinjens WNM, Van Der Weiden MM, Schroeder FH, Bosman FT, Trapman J: Frequency and characterization of p53 mutations in primary and metastatic human prostate cancer. Int J Cancer 56:630-633, 1994.
17. Uchida T, Wada C, Shitara T, Egawa S, Koshiba K: Infrequent involvement of p53 gene mutations in the tumorigenesis of Japanese prostate cancer. Br J Cancer 68:751-755, 1993.
18. Watanabe M, Ushijima T, Kakiuchi H, Shiraishi T, Yatani R, Shimazaki J, Kotake T, Sugimura T, Nagao M: p53 gene mutations in human prostate cancers in Japan: Different mutation spectra between Japan and Western countries. Jpn J Cancer Res 85:904-910, 1994.
19. Effert PJ, McCoy RH, Walther PJ, Liu ET: p53 gene alterations in human prostate carcinoma. J Urol 150: 257-261, 1993.
20. Effert PJ, McCoy RH, Walther PJ, Liu ET: Alterations of the p53 gene are associated with the progression of a human prostate carcinoma. J Urol 147:789-793, 1992.
21. Navone NM, Troncoso P, Pisters LL, Goodrow TL, Palmer JL, Nichols WW, von Eschenbach AC, Conti CJ: p53 protein accumulation and gene mutation in the progression of human prostate carcinoma. J Natl Cancer Inst 85:1657-1669, 1993.
22. Zur Hausen H: Papillomaviruses as carcinomaviruses. Adv Viral Oncol 8:1-26, 1989.
23. McNicol PJ, Dodd JG: High prevalence of human papillomavirus in prostate tissues. J Urol 145:850-853, 1991.
24. Anwar K, Nakakuki K, Shiraishi T, Naiki H, Yatani R, Inuzuka M: Presence of ras oncogene mutations and human papillomavirus DNA in human prostate carcinomas. Cancer Res 52:5991-5996, 1992.
25. Higgins GD, Uzelin DM, Phillips GE, Villa LL, Burrell CJ: Differing prevalence of human papillomavirus RNA in penile dysplasias and carcinomas may reflect differing etiologies. Am J Clin Pathol 97:272-278, 1992.
26. McCance DJ, Kalache A, Ashdown K, Andrade L, Menezes F, Smith P, Doll R: Human papillomavirus types 16 and 18 in carcinomas of the penis from Brazil. Int J Cancer 37:55-59, 1986.
27. Villa LL, Brentani RR: Human papillomavirus up-date. Int J Cancer 48:163-166, 1991.
28. Fujita M, Inoue M, Tanizawa O, Iwamoto S, Enomoto T: Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection. Cancer Res 52:5323-5328, 1992.
29. Scheffner M, Münger K, Byrne JC, Howley PM: The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc Natl Acad Sci USA 88:5523-5527, 1991.
30. Crook T, Wrede D, Vousden KH: p53 point mutation in HPV negative human cervical carcinoma cell lines. Oncogene 6:873-875, 1991.
31. Shaulsky G, Goldfinger N, Rotter V: Alterations in tumor development in vivo mediated by expression of wild type or mutant p53 proteins. Cancer Res 51:5232-5237, 1991.